PavelRoshanov Profile Banner
Pavel Roshanov Profile
Pavel Roshanov

@PavelRoshanov

Followers
471
Following
922
Statuses
986

Nephrologist-scientist @WesternU and @LHSCCanada, Scientist @LHSCRI; Investigator @PHRIresearch

London, Ontario
Joined May 2010
Don't wanna be here? Send us removal request.
@PavelRoshanov
Pavel Roshanov
13 days
Landmark analysis of 2 prospective studies (N=45K) reveals preoperative kidney function as a dominant predictor of cardiac complications in non-cardiac surgery. eGFR contributes the most predictive information - far exceeding established risk factors like coronary artery disease, diabetes, and previous stroke. A 50-year-old with eGFR of 30 approximates the cardiac risk of an 80-year-old with eGFR of 90. These findings challenge current risk calculators that rely on binary kidney function thresholds of serum creatinine. Full paper: Editorial:
Tweet media one
Tweet media two
1
2
6
@PavelRoshanov
Pavel Roshanov
13 days
The analyses demonstrate the value of modeling continuous variables like eGFR as continuous with flexible functions that allow for departures from linearity. Much thanks to the excellent work of @f2harrell in the rms package and his book on Regression Modeling Strategies that made this possible.
1
0
1
@PavelRoshanov
Pavel Roshanov
13 days
RT @f2harrell: The R rms package, now 34 years old, has a massive update. A key new #Statistics capability is profile likelihood confidenc…
0
39
0
@PavelRoshanov
Pavel Roshanov
4 months
RT @AmitXGarg: I'm excited to present the late-breaking study "Effect of a Perioperative Hypotension Avoidance Strategy vs. a Hypertension…
0
3
0
@PavelRoshanov
Pavel Roshanov
7 months
RT @Richard_D_Riley: *NEW pre-print* "Extended sample size calculations for evaluation of prediction models using a threshold for classifi…
0
16
0
@PavelRoshanov
Pavel Roshanov
9 months
RT @mvaduganathan: Wow, game-changing #SELECT data out at #HeartFailure2024! Sema 2.4mg ⬇️ CVd+HF events by 21% in HF subgroup of n=4,286…
0
105
0
@PavelRoshanov
Pavel Roshanov
9 months
0
0
0
@PavelRoshanov
Pavel Roshanov
9 months
@hswapnil @CSNSCN @turbo_dc Congrats to brilliant @turbo_dc who I get to work with closely thanks to @lastwalsh
1
0
4
@PavelRoshanov
Pavel Roshanov
9 months
RT @Nefrontera: 👏🏽Nice timeline of major trials of uremic solute removal by @PavelRoshanov at #CSNAGM @CSNSCN
Tweet media one
0
11
0
@PavelRoshanov
Pavel Roshanov
9 months
RT @turbo_dc: Swapnil putting on a show at the Top 10 Trials session CSN AGM @CSNSCN @CNTN_RCEN complete with amazing @NephJC visual abstra…
0
5
0
@PavelRoshanov
Pavel Roshanov
2 years
@docSandraO @PHRIresearch I can think of few scenarios--focused squarely around quality of life--where it seems appropriate to use mortality as a non-inferiority outcome.
1
0
1
@PavelRoshanov
Pavel Roshanov
2 years
RT @docSandraO: When one gets an opportunity to run with an idea from a great scholar & be guided by great scholars…
0
3
0
@PavelRoshanov
Pavel Roshanov
2 years
RT @CaroAlba05: Risk #models make accurate #predictions in #heartfailure. Physicians significantly overestimate risk. When absolute risk is…
0
10
0
@PavelRoshanov
Pavel Roshanov
2 years
RT @LGHemkens: Saying trials dont measure "real world effects" because they exclude patients with comorbidities is not evidence based: "We…
0
19
0